SCO CAPITAL PARTNERS LLC 4
4 · ABEONA THERAPEUTICS INC. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
SCO CAPITAL PARTNERS LLC
10% Owner
Transactions
- Sale
Common Stock
2021-01-14$2.00/sh−31,600$63,213→ 11,887,692 total(indirect: By LLC) - Sale
Common Stock
2021-01-15$2.02/sh−81,283$164,086→ 11,806,409 total(indirect: By LLC) - Sale
Common Stock
2021-01-19$2.08/sh−207,117$431,218→ 11,599,292 total(indirect: By LLC)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.